Stifel Nicolaus downgrades Pharmasset, Inc. (Nasdaq: VRUS) from Buy to Hold and sets a fair value price target of $21 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE